Neuroimaging in psychiatry;Zobrazovací metody v psychiatrii

Psychiatrie

Volumn 5, Issue SUPPL. 3, 2001, Pages 23-28

  Kopecek M ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

Author keywords

CT; MR; PET; Psychiatry; SPECT

Indexed keywords

AMISULPRIDE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

BRAIN DISEASE; BRAIN METABOLISM; BRAIN PERFUSION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC IMAGING; HUMAN; POSITRON EMISSION TOMOGRAPHY; PSYCHIATRY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

EID: 0034833329     PISSN: 12117579     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (53)

1. Playing with dopamine release
2. Increased striatal dopamine transmission in schizophrenia: Confirmation in a second cohort
3. Importance of pharmacologic control in PET studies: Effects of thiothixene and haloperidol on cerebral glucose utilization in chronic schizophrenia
4. Functional imaging of brain systems mediating obsessive-compulsive disorder
5. Regional cerebral blood flow in depression measured by positron emission tomography: The relationship with clinical dimensions
6. Serotonin 5-HT2 receptor imaging in major depression: Focal changes in orbito-insular cortex
7. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method
8. Effects of clozapine and thiothixene on glucose metabolic rate in schizophrenia
9. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia
10. Nové mozek zobrazující techniky, v psychiatrii
11. PET imaging of serotonin 1A receptor binding in depression
12. Single-photon emission computed tomography with 99mTc-exametazime in unmedicated schizophrenic patients
13. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects
14. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs
15. Nonoxidative glucose consumption during focal physiologic neural activity
16. D(2) and 5HT(2A) receptor occupancy of different doses of quetiapine in schizophrenia: A PET study
17. Hemnorrhage
18. Metabolic mapping of functional activity in human subjects with the [18F]fluorodeoxyglucose technique
19. Magnetická rezonanční spektroskopie v psychiatrii
20. Funkčni magnetická rezonance a evokované potenciály - Základní principy a aplikace
21. High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: A PET study
22. The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: A PET study
23. Relationship between dopamine D(2) occupancy, clinical response, and side effects: A double-blind PET study of first-episode schizophrenia
24. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia
25. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: A PET investigation
26. Reduced benzodiazepine receptor binding in panic disorders measured by iomazenil SPECT
27. Jak často podávat antipsychotika?
28. Funkční zobrazovací metody v neuropsychiatrii: Metody, možnosti a omezení
29. Abnormal regional benzodiazepine receptor uptake in the prefrontal cortex in patients with panic disorder
30. Alzheimerova choroba v nálezech funkčních zobrazovacích metod. Vyšetření regionálního průtoku krve mozkem pomocí 99mTc-HMPAO SPECT
31. Dopamine as the wind of the psychotic fire: New evidence from brain imaging studies
32. Dopamine D2 receptor occupancy by olanzapine or risperidone in young patients with schizophrenia
33. Vyšetření regionální mozkové perfuze pomocí jednofotonové emisni tomografie (SPECT v psychiatrii
34. Patterns of cerebral blood flow in schizophrenia
35. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: Preliminary results from a quantitative PET study
36. In vivo characteristics of dopamine D2 receptor occupancy by amisulpride in schizophrenia
37. The effect of antipsychotic medication on relative cerebral blood perfusion in schizophrenia: Assessment with technetium-99m hexamethyl-propyleneamine oxime single photon emission computed tomography
38. D1, D2, and 5-HT2 receptor occupancy in relation to clozapine serum concentration: A PET study of schizophrenic patients
39. Suggested minimal effective dose of risperidone based on PET-measured D2 and 5-HT2A receptor occupancy in schizophrenic patients
40. Positron emission tomography studies on D2 dopamine receptor occupancy and plasma antipsychotic drug levels in man
41. In vivo determination of striatal dopamine D2 receptor occupancy in patients treated with olanzapine
42. Correlation between regional cerebral blood flow and oxidative metabolism. In vivo studies in man
43. Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: Effects of depression and antidepressant treatment
44. Metabolic mapping of functional activity in the hypothalamo-neurohypophysial system of the rat
45. Neurochemical brain imaging investigations of schizophrenia
46. The functional neuroanatomy of mood disorders
47. The [14C] deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat
48. A clinical role for 99mTc-HMPAO SPECT in the investigation of dementia?
49. Imaging the living human brain: Magnetic resonance imaging and positron emission tomography
50. Brain disease and psychiatric illness: When should a psychiatrist order a CAT scan?
51. Brain serotonin2 receptors in major depression: A positron emission tomography study